Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $3.3 million.

  • Coeptis Therapeutics Holdings' Total Liabilities fell 1783.54% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 1783.54%. This contributed to the annual value of $5.0 million for FY2024, which is 3418.33% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Total Liabilities of $3.3 million as of Q3 2025, which was down 1783.54% from $5.1 million recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' 5-year Total Liabilities high stood at $10.4 million for Q2 2021, and its period low was $310060.0 during Q2 2024.
  • For the 5-year period, Coeptis Therapeutics Holdings' Total Liabilities averaged around $4.8 million, with its median value being $4.6 million (2022).
  • In the last 5 years, Coeptis Therapeutics Holdings' Total Liabilities plummeted by 9403.19% in 2024 and then surged by 154850.32% in 2025.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Total Liabilities stood at $4.4 million in 2021, then dropped by 21.58% to $3.5 million in 2022, then increased by 8.51% to $3.8 million in 2023, then surged by 34.18% to $5.0 million in 2024, then tumbled by 35.24% to $3.3 million in 2025.
  • Its Total Liabilities stands at $3.3 million for Q3 2025, versus $5.1 million for Q2 2025 and $6.0 million for Q1 2025.